The subsequent enhanced release of M1 mediators derived from KCs will then lead to the pathogenesis of various liver lesions, including steatosis, apoptosis, inflammatory cell recruitment, and fibrosis (Reid et al., 2016; Zhang Y. et al., 2023). The gene discussed is TBCE; the disease is steatosis.